.

Vanda Pharmaceuticals reported $496.9M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 532.52M 9.7M
Acorda Therapeutics ACOR:US $ 76.52M 3.93M
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
Akebia Therapeutics AKBA:US $ 304.16M 1.48M
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Anika Therapeutics ANIK:US $ 167.86M 2.53M
Arrowhead Research ARWR:US $ 432.39M 14.76M
AstraZeneca AZN:LN 20.92B 1.73B
Bluebird Bio BLUE:US $ 167.46M 87.46M
Bristol Myers Squibb BMY:US $ 30186M 65M
Clovis Oncology CLVS:US $ 142.28M 43.25M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Enanta Pharmaceuticals ENTA:US $ 313.04M 28.83M
Esperion Therapeutics ESPR:US $ 252.48M 38.34M
Halozyme Therapeutics HALO:US $ 541.94M 446.75M
Heron Therapeutics HRTX:US $ 194.21M 28.38M
Insmed INSM:US $ 674.73M 81.41M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
Ligand Pharmaceuticals LGND:US $ 243.78M 32.28M
Minerva Neurosciences NERV:US $ 50.04M 5.66M
Moderna Inc MRNA:US 13.56B 2.79B
Novartis NVS:US $ 38142M 906M
Ptc Therapeutics PTCT:US $ 694.68M 79.33M
Puma Biotechnology PBYI:US $ 114.28M 3.29M
Sangamo Biosciences SGMO:US $ 343.12M 3.06M
Takeda 4502:JP Y 2549515M 44127M
Teva Pharmaceutical TEVA:IT 12.16B 287M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
Vanda Pharmaceuticals VNDA:US $ 496.9M 4.63M
Veracyte VCYT:US $ 235.04M 3.44M